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Abstract
Background: Intensity modulated proton therapy (IMPT) of head and neck (H&N) tumors may benefit from plan
adaptation to correct for the dose perturbations caused by weight loss and tumor volume changes observed in
these patients. As cone beam CT (CBCT) is increasingly considered in proton therapy, it may be possible to use
available CBCT images following intensity correction for plan adaptation. This is the first study exploring IMPT plan
adaptation on CBCT images corrected and delineated by deformable image registration of the planning CT (pCT) to
the CBCT, yielding a virtual CT (vCT).
Methods: A Morphons algorithm was used to deform the pCTs and corresponding delineations of 9 H&N cancer
patients to a weekly CBCT acquired within ±3 days of a control replanning CT scan (rpCT). The IMPT treatment
plans were adapted using the vCT and the adapted and original plans were recalculated on the rpCT for dose/
volume parameter evaluation of the impact of adaptation.
Results: On the rpCT, the adapted plans were equivalent to the original plans in terms of target volumes D95 and
V95, but showed a significant reduction of D2 in these volumes. OAR doses were mostly equivalent or reduced. In
particular, the adapted plans did not reduce parotid gland Dmean, but the dose to the optical system. For three
patients the spinal cord or brain stem received higher, though well below tolerance, maximum dose. Subsequent
tightening of the treatment planning constraints for these OARs on new vCT-adapted plans did not degrade target
coverage and yielded pCT equivalent plans on the vCT.
Conclusions: An offline automated procedure to generate an adapted IMPT plan on CBCT images was developed
and investigated. When evaluating the adapted plan on a control rpCT we observed reduced D2 in target volumes
as major improvement. OAR sparing was only partially improved by the procedure. Despite potential limitations in
the accuracy of the vCT approach, an improved quality of the adapted plans could be achieved.
Keywords: Intensity modulated proton therapy, Cone beam CT, Adaptive radiation therapy, Deformable image
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Background
Intensity modulated radiation therapy (IMRT) with pho-
tons can be considered current state-of-the-art for the
treatment of head and neck (H&N) cancer [1–3]. However,
intensity modulated proton therapy (IMPT) using spot
scanning has been shown to yield superior dose distribu-
tions compared to IMRT for the treatment of H&N cancer
patients [4–8]. Still, plan adaptation may be desirable to op-
timally treat patients undergoing weight loss or other ana-
tomical modifications during the radiation course [9–11].
To enable adaptive radiation therapy (ART), a time point
for re-planning needs to be chosen and a new delineated
diagnostic quality computed tomography (CT) image of the
patient is required. The time point may be fixed for all
patients based on clinical experience, or a patient specific
action level may be derived based on e.g., evaluation of the
dose of the day. It is thus obvious that access to frequent,
delineated diagnostic CT quality images is of high import-
ance in an adaptive workflow.
In-room cone beam CT (CBCT) imaging, which is in-
creasingly considered for proton therapy [12], provides in-
formation related to patient positioning as well as
anatomical variations. However, direct dose calculation on
CBCT images is not recommended for IMPT [13] due to
their poor image quality [14, 15]. Previous work [16–21]
suggests that it is feasible to apply deformable image regis-
tration (DIR) to the original delineated planning CT
(pCT) image to match the anatomy observed on CBCT
images. This method of CBCT intensity correction yields
an image, referred to as virtual CT (vCT) in this work,
suitable to IMPT dose calculation [22–26] and automatic-
ally yields updated contours from the DIR [18, 23, 27]. A
previous evaluation in terms of matching features and
Dice coefficient showed good agreement between vCT
contours and those from a physician [23].
The availability of a delineated CT image fulfills the
basic technical requirements for adaptation of the IMPT
plan. Furthermore, the automated nature of the vCT
generation and delineation may allow for plan adaptation
with little increase to the clinical workload. To the best of
our knowledge there is no study in the literature reporting
on plan adaptation for IMPT based on CBCT images. In
this study we investigated the re-optimization of the initial
IMPT plan using the automatically delineated vCT to re-
store the initial optimization objectives. We investigated
the impact of this correction by recalculating the dose
distributions from the original and updated plans on a de-
lineated control replanning CT (rpCT) image taken within
3 days of the CBCT image used to generate the vCT by
evaluating dose/volume histogram (DVH) parameters.
Methods
Clinical datasets of 9 H&N cancer patients undergoing
IMRT were employed in this study. The patient data ac-
quisition and anonymization protocol used in this study
received approval from the ethics committee of the
University Clinic of the Ludwig-Maximilians-Universität
München (LMU Munich). 6 patients had lesions of the
larynx or pharynx (Pat1-6) while 3 cases had nasal cavity
lesions (Pat7-9) as detailed in Table 1. Dose prescriptions
in this study follow the original clinical IMRT treatments.
The sizes of the target volumes can be found in Additional
file 1: Table S1. Each patient had a delineated pCT, a
CBCT and delineated rpCT from the same physician. The
pCT and rpCT images were acquired with a Toshiba
Aquilion LB scanner and reconstructed on a 1.074 mm ×
1.074 mm × 3 mm grid. The CBCT images were acquired
with the on-board Elekta Synergy Linac imager equipped
with XVI R4.5 and reconstructed on a 1 mm × 1 mm ×
1 mm grid. The scan parameters were the same as in
Landry et al. [23] IMPT plans were generated with a re-
search version of a commercial treatment planning system
(TPS) (RayStation 4.6, RaySearch Laboratories, Stockholm,
Sweden) following the approach outlined in Kurz et al. [13]:
A four field arrangement has been used for Pat1-6 with lar-
ynx or pharynx lesions (45°, 90°, 270° and 315° on the
Table 1 Patient characteristics. ΔtrpCT and ΔtCBCT are the times between planning and replanning CT acquisition and between
planning CT and CBCT acquisition respectively
Patient identifier Age Sex Tumor site TNM stage ΔtrpCT (days) ΔtCBCT (days) SIB prescription low
dose/high dose (Gy)
Number of SIB fractions
Pat1 65 M Larynx pT2pN0M0 51 50 50/- 25
Pat2 54 F Hypopharynx, esophagus cT4cN2M0 39 41 50.4/56 28
Pat3 71 M Larynx pT1bN0M0 34 35 54/60 30
Pat4 87 M Hypopharynx cT2cN2bM0 33 34 54/60 30
Pat5 49 M Nasopharynx cT2cN2bM0 40 40 54/60 30
Pat6 42 M Larynx pT2bpN1M0 44 41 50.4/56 28
Pat7 66 M Right paranasal sinus pT2cN0M0 31 30 50.4/61.6 28
Pat8 67 M Left paranasal sinus pT3N2bM0 30 30 54.4/64 32
Pat9 76 M Nasal cavity cT3N0M0 37 38 50.4/56 28
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International Electrotechnical Commission (IEC) scale,
with 90° and 270° blocked in the shoulder area), and a 3
field arrangement for Pat7-9 with nasal cavity lesions (0°,
100°, 260° on the IEC scale, with 0° blocked in the nasal/
buccal area). For eight patients simultaneous integrated
boost (SIB) plans using two dose levels (reported in Table 1)
were generated, while for one patient only a single dose
level was used, following again the dose prescriptions of the
original clinical IMRT plans. Target definition was also
adopted from clinical IMRT planning procedures. The high
dose CTV has been retrieved from expansion of the GTV
by a 5–7 mm margin, for high dose PTV generation an
additional 5–7 mm margin was applied. The low dose CTV
also covered the lymph node areas following the delineation
approach of Grégoire et al. [28] It was extended by 5–
7 mm to the low dose PTV. All treatment fields have been
optimized simultaneously (multi-field optimization). For
Pat1-6, the main PTV coverage limitation was the mean
dose to the parotid glands, since the spinal cord and brain
stem were easily spared by IMPT. For Pat7-9 the mean
dose to the eye lens and the maximum dose to the optical
nerves and chiasm were also critical. Planning risk volumes
(PRV) were used for optimization for the spinal cord, brain
stem, optical nerves and chiasm. Table 2 reports the TPS-
specific DVH objectives employed for treatment plan
optimization in this study. Treatment plans were accepted
when exceeding a V95 of 95 % in the PTVs, except from
two cases where a slightly lower V95 (94 %) was accepted
due to OAR constraints.
vCT images were generated for each CBCT by per-
forming DIR of the aligned pCT to the CBCT using a
Morphons algorithm [29], which is image intensity inde-
pendent. The tools described in Landry et al. were used
with slight modifications to the procedure. In Landry et
al. a translational registration was used for aligning the
pCT and CBCT prior to DIR [23], while in this work we
also allowed for small rotations (always below 5° in this
study) to simulate modern 6-degrees-of-freedom patient
position correction. The rigid registration was performed
on a region of interest (ROI) containing the spine and
ranging from the 1st to the 6th vertebrae for Pat1 to Pat6
and on the skull for Pat7 to Pat9. For evaluation, the
rpCT was also rigidly registered to the pCT using the
same ROIs. Manual tuning of the final registrations
yielded corrections smaller than 1 mm, confirming the
quality of the rigid registrations. The cavity correction
method described in Landry et al., where empty/full cav-
ities on the CBCT take the CT numbers of air/water on
the vCT, was used for all cases [23].
The registered rpCT and vCT were imported in the
TPS with their respective contours and the dose distri-
bution corresponding to the initial plan, optimized on
basis of the pCT, was calculated on the rpCT. A new
plan was designed on the vCT using the same
optimization parameters as the initial plan and the DIR-
based contours. The rpCT dose distribution correspond-
ing to this adapted plan was compared to the one from
the original plan using the DVH parameters listed in
Table 2 and the corresponding rpCT contours.
The median and interquartile range of the distribution
of the differences between the parameters from Table 2
evaluated for the pCT and rpCT (with and without vCT-
based plan adaptation) was computed for the 9 patients.
DVH parameters with and without plan adaptation for
the rpCT were also compared by a paired Wilcoxon
signed-rank test in order to find statistically significant
differences caused by plan adaptation on basis of the
vCT.
Results
Figure 1 shows IMPT dose distributions from the original
plan computed on the pCT and rpCT as well as the vCT-
adapted plan on the rpCT (labelled rpCTadapt) and on the
vCT (labelled vCTadapt) for two representative patients.
Table 2 DVH parameters used in this study. Planning risk volumes were used for the brain stem, spinal cord, optic nerves and optic
chiasm. Dprescr. is the prescription dose. The TPS-specific DVH objectives used in treatment plan optimization are also presented
Organ at risk or target DVH parameters evaluated DVH objectives used for planning
High dose PTV D95, D2, V95 V95 = 100 %, Dmin = 100 % · Dprescr., Dmax < 105 % · Dprescr.
High dose CTV D95, D2
Low dose PTV D95, D2, V95 V95 = 100 %, Dmin = 100 % · Dprescr., Dmax < 105 % · Dprescr.
Low dose CTV D95, D2
Parotid glands Dmean Dmean < 26 Gy
Spinal cord D2 Dmax < 53 Gy
Brain stem D2 Dmax < 53 Gy
Optical nerves D2 Dmax < 54 Gy
Optical chiasm D2 Dmax < 56 Gy
Eye D2 Dmax < 45 Gy
Eye lens Dmean Dmean < 10 Gy
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Over-dosed regions in the low dose PTV were observed
on the rpCT in the vicinity of the high dose PTV and the
skin when applying the original plan for Pat2. This over-
dosage was reduced by adapting the plan using the vCT.
For Pat5 over-dosage was observed (up to 109 % of the
high dose PTV prescription dose, which corresponds to
about 120 % of the low dose PTV prescription dose) in
the high dose PTV and could be eliminated in the adapted
plan. In both cases, dose distributions of the adapted plan
on the vCT were found similar to the original planning
scenario (pCT).
Figure 2 presents DVH curves for the original plan on
the pCT and rpCT as well as the adapted plan on the
rpCT and the vCT for the same two patients presented
in Fig. 1. For both patients, over-dosed regions were ob-
served in the low dose and high dose PTVs for the ori-
ginal plan on the rpCT. For Pat5, the target coverage of
the original plan for the low dose PTV was degraded on
the rpCT (D95 reduction of 4 Gy); for the adapted plan,
coverage was almost recovered. The adapted plans miti-
gated over-dosage (above 105 % of prescription) for both
targets and both patients. The spinal cord D2 was similar
for the pCT, rpCT and rpCT with adapted plan for Pat5,
while for Pat2 it rose from 42 Gy to 47 Gy and 45 Gy re-
spectively. The adapted plan did not reduce the spared
parotid gland Dmean for both patients. In both cases, the
adapted plan on the vCT exhibits similar DVH curves as
the original plan on the pCT.
Figures 3 and 4 present box plots of the distribution of
differences of DVH indices for the target volumes of all
patients. Absolute differences of the original and adapted
plan on the rpCT with respect to the original dose dis-
tribution on the pCT are shown (top row in Fig. 3, left
in Fig. 4), as well as DVH index differences between ori-
ginal and adapted plan on the rpCT (bottom row in
Fig. 3, right in Fig. 4). The Wilcoxon rank-sum test
Fig. 1 Dose distributions for Pat2 and Pat5 from the original plan on the pCT and rpCT as well as the adapted dose distributions on the rpCT
(rpCTadapt) and vCT (vCTadapt). The high and low dose PTVs are indicated in blue and green respectively. The spinal cord PRV is also shown. For
the high dose PTV, the 95 % dose level corresponds to 105 % on the color bar, which is relative to the low dose PTV prescription. Hot spots
correspond to 120 % or more of the low dose PTV prescription
Fig. 2 DVH curves for Pat2 and Pat5 for the high dose PTV (HD PTV), low dose PTV (LD PTV), left (L) parotid gland and spinal cord PRV for the
dose distributions of the initial plan on the pCT, rpCT and the adapted plan on the rpCT (rpCTadapt) and vCT (vCTadapt). The LD PTV excludes the
HD PTV volume expanded by a 5 mm margin
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showed that there were no significant differences in the
high and low dose CTV and PTV D95 and V95 between
the original and adapted plan on the rpCT (p > 0.05). In
terms of D2, the adapted plans showed improved results
for the high and low dose PTVs, as well as for the low
dose CTV, with p < 0.05. The effect on the high dose
CTV was less pronounced (p = 0.1, see Fig. 4).
Figure 5 shows the data for OARs in similar fashion as
Figs. 3 and 4. For OARs, the adapted plan showed no re-
markable improvement with respect to the original plan
Fig. 3 Boxplots of target DVH index (D95 left vertical axis, V95 right vertical axis) differences. The original (rpCT) and adapted plans (rpCTadapt) on
the rpCT are compared to the original plan on the pCT (top panel) and to each other (bottom panel) for the 9 patients investigated in this study.
Non-significant differences between original and adapted plan on the rpCT are indicated by ‘n.s.’. All dose values refer to the total dose of the SIB
treatment phase for ease of interpretation
Fig. 4 Boxplots of target DVH index (D2) differences. The original (rpCT) and adapted plans (rpCTadapt) on the rpCT are compared to the original
plan on the pCT (left panel) and to each other (right panel, including results of the paired Wilcoxon signed-rank test) for the 9 patients investi-
gated in this study. All dose values refer to the total dose of the SIB treatment phase
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in the spinal cord, brain stem and parotid glands. Differ-
ences between the distributions were not significant.
However, in two cases, spinal cord D2 was increased by
more than 3 Gy (28 Gy vs 24 Gy and 40 Gy vs 32 Gy)
for the adapted plan with respect to the original plan. A
considerable brain stem D2 increase by 4Gy (26 Gy vs
22 Gy) was found in one case (see red arrows in Fig. 5).
Still, for all cases the spinal cord and brain stem D2 were
well below the 53 Gy maximum dose objective used for
treatment planning. For optical nerves D2, chiasm D2,
eye D2, and eye lenses Dmean we observed a lower dose
with rpCTadapt at borderline significance (p in the order
of 0.1).
Discussion
In terms of the high and low dose PTVs and CTVs D95
and V95, the adapted plans yielded only minor differ-
ences compared to the original plans when evaluated on
the rpCT, as observed on Fig. 3. The main improvement
from the CBCT-based plan adaptation was the reduction
of over-dosage in the target volumes, as indicated by the
significantly reduced D2 values (see Fig. 4). While over-
dosage in the GTV may not be of issue, the low dose
PTV in H&N cancer patients contains normal tissue
where very high doses may not be desired.
For OARs, the adapted plans yielded improved results,
i.e., lower DVH parameter, for optical nerves, chiasm,
eyes and eye lenses with respect to the original plan. For
the spinal cord, brain stem and parotid glands, no sig-
nificant improvement by plan adaptation was found.
With respect to the original planning scenario, the
adapted plan evaluated on the rpCT shows a higher me-
dian OAR dose burden for parotid glands, brain stem
and spinal cord (see Fig. 5, top row, blue boxplots). This
indicates that the approach investigated here may not be
sufficient to ensure optimal sparing of the OARs. How-
ever, following optimization of the adapted plan on the
vCT, optimization targets for OARs, as well as all target
structures, were always met within 1–2 Gy and corre-
sponded to the original plan in terms of DVH parameter,
Fig. 5 Boxplots of OAR DVH index differences. The original (rpCT) and adapted plans (rpCTadapt) on the rpCT are compared to the original plan
on the pCT (top panel) and to each other (bottom panel, including results of the paired Wilcoxon signed-rank test) for the 9 patients investigated
in this study. Left and right eyes, optical nerves and lenses were grouped together for Pat7-9, left and right parotid glands for all patients. All dose
values refer to the total dose of the SIB treatment phase for ease of interpretation. Red arrows indicate the cases with most pronounced OAR
dose increase from original to adapted plan (see Discussion section)
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except from the above mentioned three cases with con-
siderably increased spinal cord or brain stem D2 (see
Fig. 2 and Fig. 6). This is probably due to the fact that
DVH values were far below the constraints used for plan
optimization. In these cases, the dose to the spinal cord or
brainstem, respectively, could easily be reduced to a level
similar to the original planning scenario by using tighter
constraints on the OAR dose during plan adaptation. Dose
to other OARs or target structures were not compromised
(see Additional file 1: Figure S1 for an exemplary case).
This issue might be solved by automatic constraint adap-
tation as proposed in Breedveld et al. [30].
Remaining differences of the adapted plan recalculated
on the rpCT with respect to the vCT, e.g., in terms of
the parotid glands Dmean and the low dose PTV D95 and
V95, can be due to several reasons: the IMPT plans may
not be robust and slight differences in positioning, e.g.,
different neck tilts, between rpCT and vCT may be suffi-
cient to negate optimal OAR sparing. Beyond, the DIR
contours on the vCT could be inaccurate or there could
be variations in physician contouring on the rpCT. The
pCT, CBCT and rpCT alignments were performed by fo-
cusing on a region of interest covering the 1st to 6th ver-
tebra and manual adjustment of the registration yielded
corrections of less than 1 voxel. However, by aligning
the images using the spine there may be misalignment
in other regions of the larger, low dose PTV. For a single
patient we also employed a physician delineated vCT to
generate the adapted plans and no marked differences
were observed between that plan and the one optimized
using the DIR delineation. Despite a comprehensive
evaluation of the vCT approach by our group [22, 23],
we cannot finally conclude on the basis of our patient
cohort to what extent differences between vCT and
rpCT (using the adapted plan) are related to the effects
described above or to non-contour-related inaccuracies
of the vCT. To do so, a cohort of IMPT patients with
little anatomical changes between repeated diagnostic
CT imaging might be investigated to quantify the
changes in DVH parameters solely due to re-positioning
and re-contouring. In this respect, systematically
employing automatic delineation tools may help reduce
variability in delineation [31]. To preserve the DVH pa-
rameters obtained when optimizing the plan using the
vCT it may also be necessary to employ robust
optimization, or to use either different or automatically
selected beam angles. A robust plan may provide worse
parotid sparing initially but may mitigate the increased
parotid dose observed on the rpCT.
The adapted plans were generated using a workflow
where no human interaction was required in terms of
contouring or optimization function adjustment. The
procedure could thus be automated and started follow-
ing the acquisition of the CBCT scan. Online adaptation
is not realistic with this procedure given the computa-
tional time required for DIR, optimization and dose
calculation (total of about 1 h) and the method would
thus serve to update the plan for the next fraction.
This is the setting we investigated by making use of
rpCTs acquired at a different time than the CBCT. We
can assume that the anatomical and positioning differ-
ences between the rpCT acquisition and CBCT acqui-
sition simulated the differences between two fractions.
One key aspect of the vCT approach is that the patient
anatomy and position correspond to the situation at
the treatment couch, as opposed to the rpCT scan. De-
velopment of graphics processor unit based DIR and
dose calculation may eventually allow the procedures
described here to be performed online. If the vCT ap-
proach is not used to automatically adapt the treat-
ment plan, it may still be used to evaluate the need for
adaptation by monitoring DVH parameters, dose dis-
tributions directly or changes in the water equivalent
thickness along beam paths.
Fig. 6 Boxplots of OAR DVH index differences. The vCT optimized plan on the vCT is compared to the original planning scenario (original plan
on pCT) for the 9 patients investigated in this study. Red arrows indicate the cases with most pronounced OAR dose increase for the adapted
plan. All dose values refer to the total dose of the SIB treatment phase
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Conclusion
We have established an offline automatic procedure to
generate an adapted IMPT plan on CBCT images. When
evaluating the adapted plan on a physician delineated
control rpCT we observed reduced over-dosage in the
high and low dose PTV. OAR sparing was partially im-
proved by the procedure, mainly for the optical system,
but might demand for tighter constraints during plan
adaptation. Despite potential limitations in the accuracy
of the vCT approach, an improved quality of the adapted
plans could be achieved. The implementation of the pro-
cedure in a clinical workflow would require evaluation
of the adapted plans.
Additional file
Additional file 1: Figure S1. DVH curves for Pat3. The adapted plan
(calculated on the vCT) is compared to a re-optimized plan with a tighter
constraint of 22 Gy for the maximum dose in the spinal cord. The original
adapted plan is labelled vCT on the figure, while the plan with tighter
constraints is labelled vCT OAR. Table S1. Patient target structure volumes
from the pCT and rpCT. All volumes in cm3. Patient neck volume changes
were computed using the body contour in the neck region, excluding slices
below the shoulders and above the jaw. This was not computed for patients
with nasal cavity lesions. (PDF 279 kb)
Abbreviations
ART: adaptive radiotherapy; CBCT: cone beam computed tomography;
CT: computed tomography; CTV: clinical target volume; DIR: deformable
image registration; DVH: dose/volume histogram; GTV: gross tumor volume;
H&N: head and neck; HD: high dose; IMPT: intensity modulated proton
therapy; IMRT: intensity modulated radiation therapy; L: left; LD: low dose;
OAR: organ at risk; pCT: planning CT; PRV: planning risk volume;
PTV: planning target volume; ROI: region of interest; rpCT: replanning CT;
SIB: simultaneous integrated boost; TPS: treatment planning system;
vCT: virtual CT.
Competing interest
The authors declare that they have no competing interests.
Authors’ contribution
CK performed treatment planning, data analysis, generated figures and
drafted parts of the manuscript. RN delineated planning and control CT
scans. MR was responsible of the CBCT scanner related aspects of this study.
UG performed delineation of planning and control CT scans. CT participated
in the design of the study an in the data evaluation. CB and KP were
responsible for the coordination of the study. GL performed treatment
planning, deformable image registration and drafted parts of the manuscript.
All authors read and approved the final manuscript.
Acknowledgements
This work was supported by the Federal Ministry of Education and Research
of Germany (BMBF), Grant No. 01IB13001 (SPARTA), and by the German
Research Foundation (DFG) Cluster of Excellence Munich-Centre for
Advanced Photonics (MAP).
The authors thank Guillaume Janssens and Jonathan Orban de Xivry for
sharing the REGGUI toolkit containing the implementation of the Morphons
algorithm. Helpful advice concerning IMPT treatment planning from Silvia
Molinelli, Mario Ciocca, Martin Hillbrand, Daniel Köpl, Franz Joachim Kaizer is
gratefully acknowledged. We thank Erik Traneus from RaySearch Laboratories
for his support on the RayStation TPS.
Received: 16 June 2015 Accepted: 27 April 2016
References
1. Gupta T, Hotwani C, Kannan S, Master Z, Rangarajan V, Murthy V, et al.
Prospective longitudinal assessment of parotid gland function using
dynamic quantitative pertechnate scintigraphy and estimation of dose-
response relationship of parotid-sparing radiotherapy in head-neck cancers.
Radiat Oncol. 2015;10:67. doi:10.1186/s13014-015-0371-2.
2. Studer G, Linsenmeier C, Riesterer O, Najafi Y, Brown M, Yousefi B, et al. Late
term tolerance in head neck cancer patients irradiated in the IMRT era.
Radiat Oncol. 2013;8:259. doi:10.1186/1748-717X-8-259.
3. Studer G, Rordorf T, Glanzmann C. Impact of tumor volume and systemic
therapy on outcome in patients undergoing IMRT for large volume head
neck cancer. Radiat Oncol. 2011;6:120. doi:10.1186/1748-717X-6-120.
4. Widesott L, Pierelli A, Fiorino C, Dell'oca I, Broggi S, Cattaneo GM, et al.
Intensity-modulated proton therapy versus helical tomotherapy in
nasopharynx cancer: planning comparison and NTCP evaluation. Int J Radiat
Oncol Biol Phys. 2008;72(2):589–96. doi:10.1016/j.ijrobp.2008.05.065.
5. Simone 2nd CB, Ly D, Dan TD, Ondos J, Ning H, Belard A, et al. Comparison
of intensity-modulated radiotherapy, adaptive radiotherapy, proton
radiotherapy, and adaptive proton radiotherapy for treatment of locally
advanced head and neck cancer. Radiother Oncol. 2011;101(3):376–82.
doi:10.1016/j.radonc.2011.05.028.
6. van de Water TA, Lomax AJ, Bijl HP, de Jong ME, Schilstra C, Hug EB, et al.
Potential benefits of scanned intensity-modulated proton therapy versus
advanced photon therapy with regard to sparing of the salivary glands in
oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2011;79(4):1216–24.
doi:10.1016/j.ijrobp.2010.05.012.
7. van der Laan HP, van de Water TA, van Herpt HE, Christianen ME, Bijl HP,
Korevaar EW, et al. The potential of intensity-modulated proton
radiotherapy to reduce swallowing dysfunction in the treatment of head
and neck cancer: A planning comparative study. Acta Oncol. 2013;52(3):
561–9. doi:10.3109/0284186X.2012.692885.
8. Jakobi A, Bandurska-Luque A, Stützer K, Haase R, Löck S, Wack LJ, et al.
Identification of Patient Benefit From Proton Therapy for Advanced Head
and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue
Complication Probability Analysis. Int J Radiat Oncol Biol Phys. 2015;92(5):
1165–74. doi:10.1016/j.ijrobp.2015.04.031.
9. Kraan AC, van de Water S, Teguh DN, Al-Mamgani A, Madden T, Kooy HM,
et al. Dose uncertainties in IMPT for oropharyngeal cancer in the presence
of anatomical, range, and setup errors. Int J Radiat Oncol Biol Phys. 2013;
87(5):888–96. doi:10.1016/j.ijrobp.2013.09.014.
10. Góra J, Kuess P, Stock M, Andrzejewski P, Knäusl B, Paskeviciute B, et al. ART
for head and neck patients: On the difference between VMAT and IMPT.
Acta Oncol. 2015;54(8):1166–74. doi:10.3109/0284186X.2015.1028590.
11. Müller BS, Duma MN, Kampfer S, Nill S, Oelfke U, Geinitz H, et al. Impact of
interfractional changes in head and neck cancer patients on the delivered
dose in intensity modulated radiotherapy with protons and photons. Phys
Medica. 2015;31(3):266–72. doi:10.1016/j.ejmp.2015.02.007.
12. Park S, Cho M, Kim H. On-board CBCT/CBDT for Image-guided Proton
Therapy: Initial Performance Evaluation. Int J Radiat Oncol Biol Phys. 2009;
75(Supplement Issue 3):S595–6. doi:10.1016/j.ijrob.2009.07.1361.
13. Kurz C, Dedes G, Resch A, Reiner M, Ganswindt U, Nijhuis R, et al.
Comparing cone-beam CT intensity correction methods for dose
recalculation in adaptive intensity-modulated photon and proton therapy
for head and neck cancer. Acta Oncol. 2015;54(9):1651–7. doi:10.3109/
0284186X.2015.1061206.
14. Siewerdsen JH, Jaffray DA. Cone-beam computed tomography with a flat-
panel imager: magnitude and effects of x-ray scatter. Med Phys. 2001;28(2):
220–31. doi: http://dx.doi.org/10.1118/1.1339879.
15. Fotina I, Hopfgartner J, Stock M, Steininger T, Lütgendorf-Caucig C, Georg D.
Feasibility of CBCT-based dose calculation: comparative analysis of HU
adjustment techniques. Radiother Oncol. 2012;104(2):249–56. doi:10.1016/j.
radonc.2012.06.007.
16. Zhang T, Chi Y, Meldolesi E, Yan D. Automatic delineation of on-line head-
and-neck computed tomography images: toward on-line adaptive
radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68(2):522–30. doi:10.1016/j.
ijrobp.2007.01.038.
17. Wu Q, Chi Y, Chen PY, Krauss DJ, Yan D, Martinez A. Adaptive replanning
strategies accounting for shrinkage in head and neck IMRT. Int J Radiat
Oncol Biol Phys. 2009;75(3):924–32. doi:10.1016/j.ijrobp.2009.04.047.
18. Peroni M, Ciardo D, Spadea MF, Riboldi M, Comi S, Alterio D, et al.
Automatic segmentation and online virtualCT in head-and-neck adaptive
Kurz et al. Radiation Oncology  (2016) 11:64 Page 8 of 9
radiation therapy. Int J Radiat Oncol Biol Phys. 2012;84(3):e427–33. doi:10.
1016/j.ijrobp.2012.04.003.
19. Zhen X, Gu X, Yan H, Zhou L, Jia X, Jiang SB. CT to cone-beam CT
deformable registration with simultaneous intensity correction. Phys Med
Biol. 2012;57(21):6807–26. doi:10.1088/0031-9155/57/21/6807.
20. Zhen X, Yan H, Zhou L, Jia X, Jiang SB. Deformable image registration of CT
and truncated cone-beam CT for adaptive radiation therapy. Phys Med Biol.
2013;58(22):7979–93. doi:10.1088/0031-9155/58/22/7979.
21. Veiga C, McClelland J, Moinuddin S, Lourenço A, Ricketts K, Annkah J, et al.
Toward adaptive radiotherapy for head and neck patients: Feasibility study
on using CT-to-CBCT deformable registration for “dose of the day”
calculations. Med Phys. 2014;41(3):031703. doi:10.1118/1.4864240.
22. Landry G, Dedes G, Zöllner C, Handrack J, Janssens G. Orban de Xivry J et al.
Phantom based evaluation of CT to CBCT image registration for proton
therapy dose recalculation. Phys Med Biol. 2015;60(2):595–613. doi:10.1088/
0031-9155/60/2/595.
23. Landry G, Nijhuis R, Dedes G, Handrack J, Thieke C, Janssens G, et al.
Investigating CT to CBCT image registration for head and neck proton
therapy as a tool for daily dose recalculation. Med Phys. 2015;42(3):1354–66.
doi:10.1118/1.4908223.
24. Thomson DJ, Teo B-KK, Ong A, Ang KW, Kirk M, Ahn PH, et al. The Impact of
Anatomic Change on Pencil Beam Scanning in the Treatment of Oropharynx
Cancer. Int J Part Ther. 2015;2(2):394–403. doi:10.14338/IJPT-15-00002.1.
25. Veiga C, Alshaikhi J, Amos R, Lourenco AM, Modat M, Ourselin S, et al.
Cone-beam computed tomography and deformable registration-based
“dose of the day” calculations for adaptive proton therapy. Int J Part Ther.
2015;2(2):404–14. doi:10.14338/IJPT-14-00024.1.
26. Veiga C, Janssens G, Teng C-L, Baudier T, Hotoiu L, McClelland JR, et al. First
clinical investigation of CBCT and deformable registration for adaptive
proton therapy of lung cancer. Int J Radiat Oncol Biol Phys. 2016. doi:
http://dx.doi.org/10.1016/j.ijrobp.2016.01.055.
27. Hardcastle N, Tomé WA, Cannon DM, Brouwer CL, Wittendorp PW, Dogan
N, et al. A multi-institution evaluation of deformable image registration
algorithms for automatic organ delineation in adaptive head and neck
radiotherapy. Radiat Oncol. 2012;7:90. doi:10.1186/1748-717X-7-90.
28. Grégoire V, Eisbruch A, Hamoir M, Levendag P. Proposal for the delineation
of the nodal CTV in the node-positive and the post-operative neck.
Radiother Oncol. 2006;79(1):15–20. doi:10.1016/j.radonc.2006.03.009.
29. Janssens G, de Xivry JO, Fekkes S, Dekker A, Macq B, Lambin P, et al.
Evaluation of nonrigid registration models for interfraction dose
accumulation in radiotherapy. Med Phys. 2009;36(9):4268–76. doi: http://dx.
doi.org/10.1118/1.3194750.
30. Breedveld S, Storchi PR, Keijzer M, Heemink AW, Heijmen BJ. A novel
approach to multi-criteria inverse planning for IMRT. Phys Med Biol. 2007;
52(20):6339–53. doi:10.1088/0031-9155/52/20/016.
31. Holliday EB, Frank SJ. Proton radiation therapy for head and neck cancer: a
review of the clinical experience to date. Int J Radiat Oncol Biol Phys. 2014;
89(2):292–302. doi:10.1016/j.ijrobp.2014.02.029.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Kurz et al. Radiation Oncology  (2016) 11:64 Page 9 of 9
